SDICSI 2026 年 1 月 23 日 泡泡玛特(9992.HK) IP 持续出圈印证运营能力，回购体现公司信心 事件：近期，公司在品类上做了更多的创新尝试，PUCKY 敲敲系列盲盒的出 圈、星星人怦然星动系列销售火热、以及新年马力全开系列毛绒受热捧，都印 证了公司对 IP 的运营能力，预计给 Q1 的销售带来更多增量。此外，公司近 日连续进行回购，1 月 19 日和 1 月 21 日共斥资超 3 亿港元进行回购，这也 彰显了公司对于中长期发展的信心。此前股价已从顶部下跌近 4 成，近期估值 开始修复，但仍处于合理偏低水平，推荐持续关注。 报告摘要 新品持续热销，有望给 Q1 的销售带来更多增量。近期，泡泡玛特 Pucky 敲敲 系列盲盒出圈，该产品是泡泡玛特旗下 IP 之一 Pucky 毕奇的最新系列"Pucky 敲敲系列搪胶毛绒挂件"，售价 99 元/盒，有"机敏"、"快乐"、"缘分"、"幸 运"、"智慧"、"财富"和隐藏款"成功"。产品特性是带有声音互动功能，通过 拍打毕奇脑袋，可以发出清脆的类似敲击木鱼的声音，符合当下打工人热爱玄 学的精神状态。该系列也因其敲击玩法被称为"电子木鱼"而出圈，和此 ...

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for its stock performance relative to the market [7][8]. Core Insights - The company plans to raise HKD 2.338 billion through the issuance of convertible bonds with a low interest rate of 0.75%, aimed at optimizing its capital structure and enhancing liquidity [7]. - The company has a strong fleet with an average age of approximately 4.13 years, which contributes to its competitive edge and stable performance [7]. - The company has implemented a high dividend payout policy, including a special dividend plan, which reflects its commitment to shareholder returns [7]. Financial Data and Earnings Forecast - Total revenue projections for the company are as follows: - 2023: HKD 3,745 million - 2024: HKD 4,441 million - 2025E: HKD 4,286 million - 2026E: HKD 4,541 million - 2027E: HKD 4,821 million - The revenue growth rates are expected to be 12.37% in 2023 and 18.58% in 2024, with a decline of 3.49% in 2025 [6][8]. - Net profit forecasts are as follows: - 2023: HKD 1,902 million - 2024: HKD 2,106 million - 2025E: HKD 1,969 million - 2026E: HKD 2,179 million - 2027E: HKD 2,420 million - The net profit growth rates are projected at 12.86% in 2023 and 10.73% in 2024, with a decline of 6.51% in 2025 [6][8]. - The company’s earnings per share (EPS) are expected to be: - 2023: HKD 0.31 - 2024: HKD 0.34 - 2025E: HKD 0.32 - 2026E: HKD 0.35 - 2027E: HKD 0.39 [6][8]. Operational Highlights - The company has signed contracts for six new vessels in the first half of 2025, with a total contract value of USD 308 million, all of which are mid-to-high-end vessel types [7]. - The fleet consists of 143 vessels, with 121 in operation and 22 under construction, ensuring a diversified and competitive fleet structure [7]. - The company has successfully reduced its comprehensive financing cost to 3.1%, down 40 basis points from the beginning of the year, and has decreased its debt-to-asset ratio to 65.2% [7].

Investment Rating - The report assigns a "Buy" rating for the company, indicating a positive outlook for its stock performance [5]. Core Insights - The company is leading the ADC (Antibody-Drug Conjugate) innovation wave and is expected to achieve commercialization by 2026 [2][3]. - The company has received IND approval for its self-developed ADAM9 ADC drug DB-1317, allowing clinical trials in late-stage metastatic solid tumor patients [2]. - The HER2 ADC DB-1303 has reached its primary endpoint in a Phase III clinical trial for HER2-positive unresectable or metastatic breast cancer, accelerating its market approval process [3]. - The company is expected to report multiple clinical data readouts in 2026, which could significantly impact its growth trajectory [9]. Financial Forecasts - Projected revenues for 2024, 2025, 2026, and 2027 are 1,941 million, 1,950 million, 1,972 million, and 2,100 million RMB respectively, with growth rates of 8.7%, 0.5%, 1.1%, and 6.5% [4]. - The net profit attributable to shareholders is forecasted to be -1,050 million, -247 million, -386 million, and -341 million RMB for the same years, reflecting growth rates of -193.8%, 76.5%, -56.1%, and 11.5% [4]. - Earnings per share (EPS) are expected to be -11.75, -2.76, -4.31, and -3.82 RMB for 2024, 2025, 2026, and 2027 respectively [4]. Clinical Development and Pipeline - The company is advancing its ADC pipeline, including DB-1316, which aims to address existing ADC resistance issues and is set to enter clinical stages soon [9]. - Collaborations with BioNtech are expected to yield significant clinical data in 2026, enhancing the company's competitive position in the ADC market [9].

Investment Rating - The report maintains a "Buy" rating for the company [2] Core Insights - The company plans to raise HKD 2.338 billion through the issuance of convertible bonds with a low interest rate of 0.75%, which is below the current financing cost of 3.1%. This will help optimize the capital structure and enhance liquidity [7] - The company has a young and diverse fleet, with an average age of 4.13 years and a long average remaining lease term of 7.64 years, which contributes to stable performance [7] - The company has maintained a high dividend payout ratio and announced a special dividend of HKD 0.06 per share, indicating a strong commitment to shareholder returns [7] - The financial forecasts for 2025-2027 project net profits of HKD 20 billion, HKD 22 billion, and HKD 24 billion respectively, with corresponding P/E ratios of 7, 6, and 5 [7] Financial Data and Profit Forecast - Total revenue is projected to grow from HKD 3,745 million in 2023 to HKD 4,821 million in 2027, with a peak growth rate of 18.58% in 2024 [6] - Net profit is expected to increase from HKD 1,902 million in 2023 to HKD 2,420 million in 2027, with a growth rate of 12.86% in 2023 [6] - Earnings per share are forecasted to rise from HKD 0.31 in 2023 to HKD 0.39 in 2027 [6]

Investment Rating - The report assigns a "Buy" rating to the company with a target price of HKD 15.00, representing a potential upside of 37.7% from the current price of HKD 10.89 [6]. Core Insights - The company is expected to achieve a net profit of HKD 2.53 billion to HKD 2.57 billion in 2025, reflecting a growth of 45% to 60% compared to 2024, which aligns with the company's equity incentive targets [8]. - The TV segment has shown significant improvement, with a 5.3% increase in TV shipments to 21.08 million units in the first three quarters of 2025, and a remarkable 153% growth in global shipments of TCL MiniLED TVs [8]. - A joint venture with Sony is set to enhance global and high-end development, with TCL holding a 51% stake. This partnership is expected to leverage TCL's supply chain and cost control advantages alongside Sony's advanced imaging technology and brand value [8]. - The report anticipates that the collaboration will allow TCL to transition from "scale expansion" to "brand globalization," enhancing its market share in high-end segments [8]. Financial Summary - Revenue is projected to grow from HKD 78.99 billion in 2023 to HKD 153.96 billion by 2027, with a compound annual growth rate (CAGR) of 13.5% [4]. - The gross profit margin is expected to stabilize around 15.7% by 2027, with net profit increasing from HKD 744 million in 2023 to HKD 3.51 billion in 2027 [4][9]. - Earnings per share (EPS) is forecasted to rise from HKD 0.33 in 2023 to HKD 1.39 in 2027, indicating a strong growth trajectory [4][9]. - The company’s price-to-earnings (P/E) ratio is projected to decrease from 32.9x in 2023 to 7.8x by 2027, suggesting an attractive valuation as earnings grow [4].

港股通 回购彰显成长信心，产品持续出奇创新 证券研究报告 泡泡玛特 (9992 HK) | 华泰研究 | | | 动态点评 | 投资评级(维持): | 买入 | | --- | --- | --- | --- | --- | --- | | 2026 年 | 1 月 | 22 日│中国香港 | 消费轻工 | 目标价(港币): | 410.00 | 公司近日开启股份回购，1 月 19 日、21 日两次回购合计 190 万股，回购金 额 3.1 亿港元。公司曾于 4M23-2M24 持续回购，累计约 2465 万股，金额 约 4.6 亿港元，平均单笔 36 万股。本轮回购的单笔金额及股数均超过以往， 彰显公司对成长前景信心。公司在门店运营精细度、场景氛围、情感体验等 方面不断精进，已长期论证的 IP 创新、品类创新能力持续发力，不断带动 新 IP、新玩法出圈。我们看好公司在 26 年加快 IP 结构多元化、均衡化， 乐园、动画内容、甜品、饰品等业态加快落地，培育新增长点并强化 IP 情 感连接，缓解市场对时尚风险的担忧。维持"买入"评级，继续重点推荐。 新品玩法、创意不断出新，持续验证 IP 运营能力 近期公司多 ...

Investment Rating - The investment rating for the company is "Buy" [1][6]. Core Insights - The report highlights a significant increase in same-store sales, with a year-on-year growth of 21.4% in mainland China for FY26Q3, driven by a 53.4% increase in priced jewelry sales [10]. - The company is experiencing a shift towards higher-margin priced products, with the proportion of priced jewelry sales in mainland China rising to 40.1%, an increase of 10.7 percentage points year-on-year [10]. - Online sales are showing strong growth, with a year-on-year increase of 25.3% in FY26Q3, while the total number of physical stores is decreasing [10]. Financial Summary - Total revenue is projected to grow from HKD 89,656 million in FY2025 to HKD 103,903 million in FY2028, reflecting a compound annual growth rate (CAGR) of approximately 5.4% [4]. - Gross profit is expected to increase from HKD 26,455 million in FY2025 to HKD 31,691 million in FY2028, with a gross margin of around 30.5% by FY2028 [4]. - Net profit attributable to shareholders is forecasted to rise significantly from HKD 5,916 million in FY2025 to HKD 11,153 million in FY2028, indicating a strong recovery and growth trajectory [4]. Market Data - The current stock price is HKD 14.12, with a market capitalization of HKD 139,299 million [1][7]. - The stock has traded within a range of HKD 6.76 to HKD 16.63 over the past 52 weeks [7]. Forecast and Valuation - The report maintains a target price of HKD 19.8 for FY2026, based on a price-to-earnings (P/E) ratio of 22 times [10]. - The forecasted earnings per share (EPS) for FY2026 is expected to be HKD 1.02, with a P/E ratio of 13.44 for FY2026 [11].

Investment Rating - The report maintains an "OUTPERFORM" rating for Baidu Group [2] Core Views - Baidu's operating cash flow is expected to remain positive in Q4, supported by prudent spending and the integration of AI tools in operations [4][13] - The listing of Kunlun Chip (KLX) is anticipated to unlock significant valuation for Baidu, with potential revenue comparable to Cambricon [5][14] - Apollo Go is set to accelerate its global expansion in 2026, which may further support Baidu's stock performance [15] Financial Summary - Baidu's revenue for FY25 is projected at RMB 128.7 billion, a decrease of 2.4% year-on-year, with a net profit of RMB 18.6 billion, down 31% [3][11] - The core business is expected to generate an adjusted operating profit of RMB 14.1 billion, corresponding to a margin of 13.8% [11] - For Q4, total core revenue is estimated at RMB 25.8 billion, reflecting a year-on-year decline of 6.9% but a quarter-on-quarter increase of 4.5% [12] Valuation and Recommendations - The report employs a Sum-of-the-Parts (SoTP) valuation method, estimating a total market cap of approximately HK$481.8 billion or a target price of HK$178, corresponding to a 24x PE for FY26 [6][14] - The valuation breakdown includes traditional search ads, AI cloud, AI SaaS, AI ads, and other segments, with significant contributions from the Robotaxi and Kunlun Chip businesses [6][15]

Investment Rating - The report maintains a "Buy" rating for the company, indicating a potential upside of over 15% relative to the benchmark index [3][13]. Core Insights - The company is expected to achieve a revenue of at least 3 billion RMB in 2025, representing a year-on-year growth of no less than 16%. Adjusted net profit is projected to be at least 380 million RMB, with a year-on-year increase of no less than 40% [9]. - The company's performance is driven by both organic growth and external expansion, with significant contributions from the acquisition of the second-ranked beauty brand, Nair, enhancing market share and profitability [9]. - The successful acquisition of Shanghai Siyuanli, a well-known brand in the high-end beauty service sector, is expected to further strengthen the company's market position and resource density [9]. - The integration of the top three brands in the industry is anticipated to continuously release the company's leading effect, promoting a "super brand, super chain, and super digitalization" strategy to reshape the beauty industry's value space [9]. Financial Projections - Revenue forecasts for 2025-2027 are 30.20 billion RMB, 39.86 billion RMB, and 45.84 billion RMB, with growth rates of 17.4%, 32.0%, and 15.0% respectively [3][11]. - Adjusted net profit is projected to be 3.85 billion RMB in 2025, 5.10 billion RMB in 2026, and 6.00 billion RMB in 2027, with year-on-year growth rates of 52.8%, 32.4%, and 17.6% respectively [3][11]. - The earnings per share (EPS) based on adjusted net profit is expected to be 1.53 RMB in 2025, 2.03 RMB in 2026, and 2.38 RMB in 2027, with corresponding price-to-earnings (P/E) ratios of 17, 13, and 11 [3][11].

Investment Rating - The investment rating for the company is "Buy" and is maintained [8]. Core Insights - The company is set to launch its high-speed rail branded train in July 2025 and initiate renovations for its first store in Hong Kong, which will elevate the brand to a new level. By November, the total number of stores (including sub-brands) exceeded 800, and by December, the number of self-operated stores surpassed 810, exceeding the annual target. The company is expected to accelerate its layout around three core directions: globalization, digitalization, and sustainability, leveraging its supply chain to enhance its brand presence in existing cities and enter new ones. The "Cai Shou" brand is expected to become the company's second-largest brand, aligning with current consumer trends in the restaurant industry. With standardized management, a complete supply chain, and an excellent single-store model, the company is poised to seize growth opportunities amid industry recovery [2][9]. Summary by Sections Recent Developments - In November 2025, the company announced a share incentive plan to grant shares in the form of options and restricted stock units to qualified participants. In January 2026, a joint venture will be established to engage in various businesses, including an online mall and "community ready-to-eat stores" [6][9]. Business Expansion and Strategy - The company has achieved significant milestones with over 800 stores by November and over 810 self-operated stores by December, surpassing its annual goals. The focus on globalization, digitalization, and sustainability is expected to drive future growth. The company is well-positioned to capitalize on the recovery in the restaurant industry through effective management and supply chain capabilities [2][9]. Financial Projections - The company is projected to achieve net profits attributable to shareholders of 708 million, 848 million, and 1.007 billion yuan for the years 2025, 2026, and 2027, respectively. The corresponding price-to-earnings ratios are expected to be 13, 11, and 9 times based on the current stock price [9].